[
1. Brown JC, Gerhardt TE, Kwon E. Risk factors for coronary artery disease. Treasure Island (FL): StatPearls Publishing; 2022.
]Search in Google Scholar
[
2. Gupta RM, Hadaya J, Trehan A, Zekavat SM, Roselli C, Klarin D, et al. A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression. Cell 2017;170(3):522-33.e15.10.1016/j.cell.2017.06.049578570728753427
]Search in Google Scholar
[
3. Adlam D, Olson TM, Combaret N, Kovacic JC, Iismaa SE, Al-Hussaini A, et al. Association of the PHACTR1/EDN1 genetic locus with spontaneous coronary artery dissection. J Am Coll Cardiol 2019;73(1):58-66.10.1016/j.jacc.2018.09.08530621952
]Search in Google Scholar
[
4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332(6163):411-5.10.1038/332411a02451132
]Search in Google Scholar
[
5. Vane JR, Anggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323(1):27-36.10.1056/NEJM1990070532301062113184
]Search in Google Scholar
[
6. Kelly JJ, Whitworth JA. Endothelin-1 as a mediator of cardiovascular disease. Clin Exp Pharmacol Physiol 1999;26(2):158-61.10.1046/j.1440-1681.1999.03011.x10065339
]Search in Google Scholar
[
7. Nishiyama SK, Zhao J, Wray DW, Richardson RS. Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction. J Appl Physiol 2017;122(2):354-60.10.1152/japplphysiol.00772.2016533860227909229
]Search in Google Scholar
[
8. Trindade M, Oigman W, Fritsch Neves M. Potential role of endothelin in early vascular aging. Curr Hypertens Rev 2017;13(1):33-40.10.2174/157340211366617041416573528413991
]Search in Google Scholar
[
9. Kostov K. The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation. Life (Basel) 2021;11(9):986.10.3390/life11090986847203434575135
]Search in Google Scholar
[
10. Barden AE, Herbison CE, Beilin LJ, Michael CA, Walters BN, Van Bockxmeer FM. Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancy. J Hypertens 2001;19(10):1775-82.10.1097/00004872-200110000-0001111593097
]Search in Google Scholar
[
11. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001;38(6):1321-4.10.1161/hy1101.09533311751711
]Search in Google Scholar
[
12. Treiber FA, Barbeau P, Harshfield G, Kang HS, Pollock DM, Pollock JS, et al. Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity. Hypertension 2003;42(4):494-9.10.1161/01.HYP.0000091266.41333.1512963677
]Search in Google Scholar
[
13. Tanaka C, Kamide K, Takiuchi S, Kawano Y, Miyata T. Evaluation of the Lys198Asn and –134delA genetic polymorphisms of the endothelin-1 gene. Hypertens Res 2004;27(5):367-71.10.1291/hypres.27.36715198485
]Search in Google Scholar
[
14. Wiltshire S, Powell BL, Jennens M, McCaskie PA, Carter KW, Palmer LJ, et al. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease. Hum Genet 2008;123(3):307-13.10.1007/s00439-008-0481-018288492
]Search in Google Scholar
[
15. Paré G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, et al. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Am J Hum Genet 2007;80(4):673-82.10.1086/513286185270417357073
]Search in Google Scholar
[
16. Uchida Y, Sugiura S, Nakashima T, Ando F, Shimokata H. Endothelin-1 gene polymorphism and hearing impairment in elderly Japanese. Laryngoscope 2009;119(5):938-43.10.1002/lary.2018119358249
]Search in Google Scholar
[
17. Zhu G, Carlsen K, Carlsen KH, Lenney W, Silverman M, Whyte MK, et al. Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations. Genes Immun 2008;9(1):23-9.10.1038/sj.gene.636444117960156
]Search in Google Scholar
[
18. Li J, Yin W, Liu MS, Mao LJ, Wang XH. Potential correlation between EDN1 gene polymorphisms with preeclampsia. Eur Rev Med Pharmacol Sci 2020;24(4):1602-8.
]Search in Google Scholar
[
19. Rizk H, Hammad A, El-Said A, Wahba Y. Endothelin-1 RS5370 gene polymorphism in primary nephrotic syndrome: a case-control study. An Pediatr (Engl Ed) 2021;95(6):406-12.10.1016/j.anpedi.2020.04.03633317978
]Search in Google Scholar
[
20. Lazurova Z, Habalova V, Mitro P. Association of polymorphisms in endothelin-1 and endothelin receptor a genes with vasovagal syncope. Physiol Res 2022;71(1):93-101.10.33549/physiolres.934689899767635043642
]Search in Google Scholar
[
21. Jarray R, Allain B, Borriello L, Biard D, Loukaci A, Larghero J, et al. Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis. Biochimie 2011;93(10):1668-75.10.1016/j.biochi.2011.07.01021798305
]Search in Google Scholar
[
22. Jarray R, Pavoni S, Borriello L, Allain B, Lopez N, Bianco S, et al. Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: new insights in atherosclerosis development. Biochimie 2015;118:151-61.10.1016/j.biochi.2015.09.00826362351
]Search in Google Scholar
[
23. Reschen ME, Lin D, Chalisey A, Soilleux EJ, O’Callaghan CA. Genetic and environmental risk factors for atherosclerosis regulate transcription of phosphatase and actin regulating gene PHACTR1. Atherosclerosis 2016;250:95-105.10.1016/j.atherosclerosis.2016.04.025491789727187934
]Search in Google Scholar
[
24. Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G, et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 2013;45(8):912-7.10.1038/ng.2676404112323793025
]Search in Google Scholar
[
25. Pérez-Hernández N, Vargas-Alarcón G, Posadas-Sánchez R, Martínez--Rodríguez N, Tovilla-Zárate CA, Rodríguez-Cortés AA, et al. PHACTR1 gene polymorphism is associated with increased risk of developing premature coronary artery disease in Mexican population. Int J Environ Res Public Health 2016;13(8):803.10.3390/ijerph13080803499748927517945
]Search in Google Scholar
[
26. O’Donnell CJ, Kavousi M, Smith AV, Kardia SL, Feitosa MF, Hwang SJ, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 2011;124(25):2855-64.10.1161/CIRCULATIONAHA.110.974899339717322144573
]Search in Google Scholar
[
27. Niemiec P, Zak I, Wita K. The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coron Artery Dis 2007;18(5):339-46.10.1097/MCA.0b013e328241d97a17627182
]Search in Google Scholar
[
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.10.1093/clinchem/18.6.499
]Search in Google Scholar
[
29. Knol MJ, VanderWeele TJ, Groenwold RH, Klungel OH, Rovers MM, Grobbee DE. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011;26(6):433-8.10.1007/s10654-011-9554-9311506721344323
]Search in Google Scholar
[
30. Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 2012;41(2):514-20.10.1093/ije/dyr218332445722253321
]Search in Google Scholar
[
31. Zou GY. On the estimation of additive interaction by use of the four-by- -two table and beyond. Am J Epidemiol 2008;168(2):212-24.10.1093/aje/kwn10418511428
]Search in Google Scholar
[
32. Chen L, Qian H, Luo Z, Li D, Xu H, Chen J, et al. PHACTR1 gene polymorphism with the risk of coronary artery disease in Chinese Han population. Postgrad Med J 2019;95(1120):67-71.10.1136/postgradmedj-2018-13629830777881
]Search in Google Scholar
[
33. Ford TJ, Corcoran D, Padmanabhan S, Aman A, Rocchiccioli P, Good R, et al. Genetic dysregulation of endothelin-1 is implicated in coronary micro-vascular dysfunction. Eur Heart J 2020;41(34):3239-52.10.1093/eurheartj/ehz915755747531972008
]Search in Google Scholar
[
34. Hartopo AB, Sukmasari I, Puspitawati I, Setianto BY. Serum endothelin-1 correlates with myocardial injury and independently predicts adverse cardiac events in non-ST-elevation acute myocardial infarction. Int J Vasc Med 2020;2020:9260812.10.1155/2020/9260812742439832832158
]Search in Google Scholar
[
35. Aggarwal PK, Jain V, Srinivasan R, Jha V. Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype. J Hypertens 2009;27(10):2044-50.10.1097/HJH.0b013e32832f7f3f19730395
]Search in Google Scholar
[
36. Iwanicka J, Iwanicki T, Niemiec P, Nowak T, Krauze J, Grzeszczak W, et al. Relationship between rs854560 PON1 gene polymorphism and tobacco smoking with coronary artery disease. Dis Markers 2017;2017:1540949.10.1155/2017/1540949565113729118461
]Search in Google Scholar
[
37. Salonen JT, Malin R, Tuomainen TP, Nyyssönen K, Lakka TA, Lehtimäki T. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ 1999;319(7208):487-9.10.1136/bmj.319.7208.4872820110454401
]Search in Google Scholar